to identify potent monoclonal antibodies to protect against COVID-19 in low and middle income countries
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-031229
Grant search
Key facts
Disease
COVID-19Start & end year
2021Known Financial Commitments (USD)
$298,807Funder
Gates FoundationResearch Location
United States of AmericaLead Research Institution
Columbia UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
N/A